Gardasil Quadrivalent HPV Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Gardasil Quadrivalent HPV Vaccine, covering 2026-03-24 to 2026-03-24. Get the full timeline:
Most recent: Clinical Trial Update: A Trial to Establish Non-inferiority of Immunogenicity of a Single-dose of CERVAVAC® Quadrivalent HPV Vaccine Compared to the Gardasil® Quadrivalent Vaccine Among Girls and Boys Aged 9 to 14 Years and in Girls/Women Aged 15 to 20 Years in Zambia [Phase 4]